Li-How Chen
8Patents
5h-index
2Co-inventors
49Inventor score
Filing activity: Feb 24, 1998 → Feb 13, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6528699B1 | Transgenically produced non-secreted proteins | Chemistry; Metallurgy | 20 | Expired |
| US6593463B1 | Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7354594B2 | Merozoite surface protein 1 lacking glycosylation sites | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7501553B2 | Non-human transgenic mammal comprising a modified MSP-1 nucleic acid | Emerging Cross-Sectional Technologies | 6 | Expired |
| US10034921B2 | Proteins with modified glycosylation and methods of production thereof | Chemistry; Metallurgy | 5 | Active |
| US7632980B1 | Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems | Emerging Cross-Sectional Technologies | 5 | Expired |
| US10174110B2 | Highly galactosylated anti-TNF-α antibodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7271312B1 | Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.